New Integrated mRNA Offering

Building on Experience and Investing in an Integrated mRNA Offering

Jessica Madigan; Normand Blais

BIOVECTRA

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

Eunseo (Ency) Lee, Ph.D; Jungkeun (Henry) Oh; Hanel Hwang

Samsung Biologics

Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.

Evonik

mRNA Manufacturing

Investing in the Future of mRNA Manufacturing

Esther Yoo, Ph.D.

Samsung Biologics

mRNA Manufacturing

Overcoming Bottlenecks in mRNA Manufacturing

Pierre Catignol; Huisub Lim

Samsung Biologics

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

mRNA

Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects

Scott Doncaster; Marc Sauer, Ph.D.

BIOVECTRA

Strategic Partnership

eTheRNA Announces Research Agreement with Merck KGaA, Darmstadt, Germany to Access mRNA Technologies

eTheRNA Immunotherapies NV

mRNA Manufacturing

Serving an Accelerated Market with mRNA Production

Mark Bamforth

Arranta Bio

Investing in mRNA Production

Michael Wourms

Arranta Bio

mRNA Manufacturing

Limiting Risk In mRNA Development and Production

Doug Kennedy

Arranta Bio

mRNA Manufacturing

Integrating a Fragmented mRNA Supply Chain

Dave Stevens

Arranta Bio

mRNA

Integrated Support Facilitates mRNA Product Development and Commercialization

Michael Wourms; Dave Stevens

Arranta Bio